Paying users zone. Data is hidden behind: .
Get 1-month access to AbbVie Inc. for $19.99, or
get full access to the entire website for at least 3 months from $49.99.
We accept:
This is a one-time payment. There is no automatic renewal.
Selected Financial Data
since 2012
Beginner level
Income Statement
AbbVie Inc., selected items from income statement, long-term trends
US$ in millions
| 12 months ended: | Net revenues | Operating earnings | Net earnings |
|---|---|---|---|
| Dec 31, 2019 | |||
| Dec 31, 2018 | |||
| Dec 31, 2017 | |||
| Dec 31, 2016 | |||
| Dec 31, 2015 | |||
| Dec 31, 2014 | |||
| Dec 31, 2013 | |||
| Dec 31, 2012 |
Based on: 10-K (filing date: 2020-02-21), 10-K (filing date: 2019-02-27), 10-K (filing date: 2018-02-16), 10-K (filing date: 2017-02-17), 10-K (filing date: 2016-02-19), 10-K (filing date: 2015-02-20), 10-K (filing date: 2014-02-21), 10-K (filing date: 2013-03-15).
Balance Sheet: Assets
AbbVie Inc., selected items from assets, long-term trends
US$ in millions
| Current assets | Total assets | |
|---|---|---|
| Dec 31, 2019 | ||
| Dec 31, 2018 | ||
| Dec 31, 2017 | ||
| Dec 31, 2016 | ||
| Dec 31, 2015 | ||
| Dec 31, 2014 | ||
| Dec 31, 2013 | ||
| Dec 31, 2012 |
Based on: 10-K (filing date: 2020-02-21), 10-K (filing date: 2019-02-27), 10-K (filing date: 2018-02-16), 10-K (filing date: 2017-02-17), 10-K (filing date: 2016-02-19), 10-K (filing date: 2015-02-20), 10-K (filing date: 2014-02-21), 10-K (filing date: 2013-03-15).
Balance Sheet: Liabilities and Stockholders’ Equity
AbbVie Inc., selected items from liabilities and stockholders’ equity, long-term trends
US$ in millions
| Current liabilities | Total debt and finance lease obligations | Stockholders’ equity (deficit) | |
|---|---|---|---|
| Dec 31, 2019 | |||
| Dec 31, 2018 | |||
| Dec 31, 2017 | |||
| Dec 31, 2016 | |||
| Dec 31, 2015 | |||
| Dec 31, 2014 | |||
| Dec 31, 2013 | |||
| Dec 31, 2012 |
Based on: 10-K (filing date: 2020-02-21), 10-K (filing date: 2019-02-27), 10-K (filing date: 2018-02-16), 10-K (filing date: 2017-02-17), 10-K (filing date: 2016-02-19), 10-K (filing date: 2015-02-20), 10-K (filing date: 2014-02-21), 10-K (filing date: 2013-03-15).
Cash Flow Statement
AbbVie Inc., selected items from cash flow statement, long-term trends
US$ in millions
| 12 months ended: | Cash flows from operating activities | Cash flows from investing activities | Cash flows from financing activities |
|---|---|---|---|
| Dec 31, 2019 | |||
| Dec 31, 2018 | |||
| Dec 31, 2017 | |||
| Dec 31, 2016 | |||
| Dec 31, 2015 | |||
| Dec 31, 2014 | |||
| Dec 31, 2013 | |||
| Dec 31, 2012 |
Based on: 10-K (filing date: 2020-02-21), 10-K (filing date: 2019-02-27), 10-K (filing date: 2018-02-16), 10-K (filing date: 2017-02-17), 10-K (filing date: 2016-02-19), 10-K (filing date: 2015-02-20), 10-K (filing date: 2014-02-21), 10-K (filing date: 2013-03-15).
Per Share Data
AbbVie Inc., selected data per share, long-term trends
US$
| 12 months ended: | Basic earnings per share 1 | Diluted earnings per share 2 | Dividend per share 3 |
|---|---|---|---|
| Dec 31, 2019 | |||
| Dec 31, 2018 | |||
| Dec 31, 2017 | |||
| Dec 31, 2016 | |||
| Dec 31, 2015 | |||
| Dec 31, 2014 | |||
| Dec 31, 2013 | |||
| Dec 31, 2012 |
Based on: 10-K (filing date: 2020-02-21), 10-K (filing date: 2019-02-27), 10-K (filing date: 2018-02-16), 10-K (filing date: 2017-02-17), 10-K (filing date: 2016-02-19), 10-K (filing date: 2015-02-20), 10-K (filing date: 2014-02-21), 10-K (filing date: 2013-03-15).
1, 2, 3 Data adjusted for splits and stock dividends.